Recombinant Data Convenes Translational Science Panel at AMIA 2012 Joint Summits

NEWTON, MA — (Marketwire) — 03/14/12 — Data, a healthcare and clinical provider, today announced that the company will lead a panel on translational bioinformatics and clinical research informatics at the 2012 Joint Summits on Translational Science held from March 19 – 23 in San Francisco. Featured presenters include clinicians, researchers, and scientists from , Cancer Center at Jefferson, and the , Irvine.

The panel will be held on Thursday, March 22 from 12:15 p.m. – 1:15 p.m. PT. Michael Kamerick, managing director of Health Systems Solutions at Recombinant Data, will moderate. Panelists include:

, who will describe how he and his team created biospecimen and tumor registries and are expanding data sets to include clinical trial, ambulatory care, and biomarker data using the Recombinant Data Trust data warehouse and i2b2.

, an NCI-designated Comprehensive Cancer Center, who will present how they developed and leverage their i2b2-based iCoDE (Interactive Cohort Discovery Engine) for clinical and biospecimen data integration.

, who will discuss the UC-ReX project in which i2b2 and the Shared Health Research Information Network (SHRINE) are being used to create a federated data warehouse serving the five University of California medical center campuses: UCLA; UC, San Diego; UC, San Francisco; UC, Davis; and UC, Irvine.

Recombinant Data offers Professional Open Source Support (POSS) for institutions adopting i2b2 and other open source software projects including SHRINE, caTissue, Profiles Research Networking Software, and the Research Permission Management System, to gain the benefits of open source with the dependability of commercial software for clinical and translational research.

Recombinant provides leading-edge data warehousing and clinical intelligence solutions to healthcare providers, academic medical centers and life science researchers to deliver higher quality outcomes, accelerate personalized medicine, and lower costs. Our team of industry veterans is focused on improving the flow of reliable data to power clinical and research applications in a secure, compliant environment. For more information about Recombinant-s products and services, visit .

: @Recomdata, #recomdata, @AMIAinformatix, #TBICRI12

Chas Kielt
Corporate Marketing and Communications
617-243-3700 X366

Bill Stetson
Marketing Manager
617-243-3700 X229

  amia, city-of-hope, data-warehousing, kimmel-cancer-center, recombinant-data, translational-science